Free Trial

SA Receives R10bln Jab Funding Amid Fastest Daily Rise in Cases Since January

SOUTH AFRICA
  • Wednesday's rise in COVID cases was the sharpest daily increase since early January, with South Africa reporting 19,506 new infections. 125,970 vaccines were delivered over the same time period.
  • The World Bank, France, Germany and the US have funded SA's Aspen Pharmacare to the tune of ZAR10bln to boost vaccine production. The production will focus on the single-shot Johnson & Johnson jab for distribution across South Africa and the continent.
  • South Africa's water infrastructure requires a further ZAR120bln in funds to ensure water security over the next decade, according to the water and sanitation minister, with deteriorating water quality and pre-existing water scarcity expected to become a greater issue the longer investment is delayed.
  • Following ex-President Zuma's sentencing earlier in the week, his legal team has argued that the ruling against him is unconstitutional and they are examining their options.
  • Today, the SA Health Products Regulatory Authority is holding a briefing on vaccine registration, likely in an attempt to boost registration to combat the looming third wave of infections.
  • Beleaguered utility Eskom requires a further $10bln in order to close most of its coal-fired plants by the year 2050, according to a company spokesman. Eskom is already in talks with a number of development finance institutions in an effort to raise the cash.
  • Today focus turns to ABSA Manufacturing PMI, expected at 56.5 from 57.8. Electricity production data also crosses.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.